Iris Unina Prodmetadata only
First-in-human, phase 1, open-label study of alomfilimab, an anti-ICOS antibody, as a single agent and in combination with anti-PD-L1 in advanced malignancies
auto, research
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 350935
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.